Laskar YB, Mazumder PB. Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L. Biomed Pharmacother. 2020;127: 110153.

Article  CAS  PubMed  Google Scholar 

Paskeh MDA, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15(1):83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirzaei S, et al. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol. 2022;15(1):18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Browning L, et al. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis. Cancer Manag Res. 2018;10:6685–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aoki T, et al. Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients. Respir Res. 2019;20(1):263.

Article  PubMed  PubMed Central  Google Scholar 

Johnson C, et al. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1(1):58–70.

CAS  PubMed  PubMed Central  Google Scholar 

Kumari N, et al. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553–72.

Article  CAS  PubMed  Google Scholar 

Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014;70(1):11–20.

Article  CAS  PubMed  Google Scholar 

Shibayama O, et al. Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med. 2014;3(3):702–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puchalski T, et al. Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2010;16(5):1652–61.

Article  CAS  PubMed  Google Scholar 

Kampan NC, et al. Immunotherapeutic interleukin-6 or interleukin-6 receptor blockade in cancer: challenges and opportunities. Curr Med Chem. 2018;25(36):4785–806.

Article  CAS  PubMed  Google Scholar 

Hong SS, et al. A novel small-molecule inhibitor targeting the IL-6 receptor β subunit, glycoprotein 130. J Immunol. 2015;195(1):237–45.

Article  CAS  PubMed  Google Scholar 

Hirano T. Revisiting the 1986 molecular cloning of interleukin 6. Front Immunol. 2014;5:456.

Article  PubMed  PubMed Central  Google Scholar 

Španko M, et al. IL-6 in the ecosystem of head and neck cancer: possible therapeutic perspectives. Int J Mol Sci. 2021;22(20):11027.

Article  PubMed  PubMed Central  Google Scholar 

Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127–48.

Article  CAS  PubMed  Google Scholar 

Smith AJP, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 2009;20(1):43–59.

Article  CAS  PubMed  Google Scholar 

Azevedo A, et al. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol. 2011;2(12):384–96.

Article  PubMed  PubMed Central  Google Scholar 

Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol. 1998;10(5):654–9.

Article  CAS  PubMed  Google Scholar 

Müllberg J, et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993;23(2):473–80.

Article  PubMed  Google Scholar 

Hibi M, et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990;63(6):1149–57.

Article  CAS  PubMed  Google Scholar 

Vardam TD, et al. Regulation of a lymphocyte–endothelial–IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine. 2007;39(1):84–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zorina Y, Iyengar R, Bromberg KD. Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth*. J Biol Chem. 2010;285(2):1358–70.

Article  CAS  PubMed  Google Scholar 

Ivashkiv LB, Hu X. Signaling by STATs. Arthritis Res Ther. 2004;6(4):159–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waldner MJ, Foersch S, Neurath MF. Interleukin-6–a key regulator of colorectal cancer development. Int J Biol Sci. 2012;8(9):1248–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miao T, et al. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J Neurosci. 2006;26(37):9512.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu X, et al. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402.

Article  PubMed  PubMed Central  Google Scholar 

Masjedi A, et al. The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother. 2018;108:1415–24.

Article  CAS  PubMed  Google Scholar 

Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer. 2021;9(4): e002285.

Article  PubMed  Google Scholar 

Chien C-M, et al. Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: involvement of EGF receptor/PI3K/Akt signaling pathway. Eur J Pharmacol. 2010;636(1):52–8.

Article  CAS  PubMed  Google Scholar 

Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):20.

Article  PubMed